| abstract |
The purpose of the present invention is to provide a combination for treating pancreatic and other cancers, which has a better-than-conventional tumor growth inhibitory effect.　This combination for treating cancer contains a compound represented in general formula (1) or a pharmaceutically acceptable salt thereof, and erlotinib. (In the formula, Me represents a methyl group, the R1s independently represent C1-5 alkylene groups, at least one of R7 and R8 is p-NO2-C6H4- or p-NR3R4-C6H4-, R3 and R4 are independently H, etc., and the other of R7 and R8 is -NH2, etc.) |